Broadwind Q2 Revenue Surges 67% to $24.3M, Swings to Positive Adjusted EBITDA
BWEN has more than doubled off its 52-week low of $1.88 on elevated volume (2.1× avg).
Summary
Broadwind's Q2 2026 revenue surged 67% to $24.3M, adjusted EBITDA turned positive at $1.6M, and the balance sheet strengthened dramatically after the Abilene sale, with cash at $17M and debt cut to $3.3M.
Key Events · Earnings and Guidance · BWEN
-
Revenue Surges 67%
Q2 2026 revenue reached $24.3 million, up from $14.5 million a year ago, driven by a 79% increase in Industrial Solutions and 24% growth in Gearing.
-
Adjusted EBITDA Turns Positive
Adjusted EBITDA swung to $1.6 million from a loss of $1.1 million in Q2 2025, reflecting higher sales and a more profitable product mix.
-
Balance Sheet Transformation
Cash jumped to $17.0 million from $457K at year-end, primarily from the $17.2 million Abilene facility sale. Total debt was reduced to $3.3 million from $9.0 million.
-
Strong Order Backlog
Backlog stood at $89.3 million with a book-to-bill ratio of 1.5x, indicating robust demand across both segments.
Analysis · BWEN · Manufacturing
A sharp operational turnaround defined Broadwind's Q2 2026. Revenue jumped 67% year-over-year to $24.3 million, fueled by a 79% surge in Industrial Solutions and 24% growth in Gearing. Adjusted EBITDA swung to a positive $1.6 million from a loss of $1.1 million a year ago, and the net loss narrowed to $639K. The balance sheet transformed after the Abilene facility sale: cash soared to $17 million from $457K at year-end, and total debt was slashed to $3.3 million from $9 million. Sustained demand is evident in a book-to-bill ratio of 1.5x and an $89.3 million backlog. With the exit from wind fabrication removing a drag, the remaining segments are now profitable at the operating level. This quarter marks a pivot from survival to growth for the precision manufacturer.
At the time of this filing, BWEN was trading at $5.09 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $125M. The 52-week trading range was $1.88 to $5.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.